New combo therapy aims to keep lung cancer from returning after surgery
NCT ID NCT04564157
First seen May 29, 2026 · Last updated Jun 18, 2026 · Updated 5 times
Summary
This phase 3 trial tests whether adding immunotherapy to standard chemotherapy after lung cancer surgery helps keep the cancer from coming back. It includes 210 adults with stage IB to IIIA non-small cell lung cancer that was completely removed. Participants are randomly assigned to receive either chemotherapy alone or chemotherapy followed by maintenance immunotherapy. The main goal is to see which group stays cancer-free longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Complejo Hospitalario de Navarra
Pamplona, Pamplona, 31008, Spain
-
Complexo Hospitalario Universitario De Vigo
Vigo, Vigo, 36204, Spain
-
Hospital Clínico San Carlos
Madrid, Madrid, 28040, Spain
-
Hospital Clínico de Valencia
Valencia, Valencia, 46010, Spain
-
Hospital Fundación de Alcorcón
Madrid, Madrid, 28922, Spain
-
Hospital General Universitario de Alicante
Alicante, Alicante, 03010, Spain
-
Hospital General Universitario de Valencia
Valencia, Valencia, 46014, Spain
-
Hospital Parc Taulí
Barcelona, Barcelona, 08208, Spain
-
Hospital Puerta de Hierro
Madrid, Madrid, 28222, Spain
-
Hospital San Pedro De Alcántara
Cáceres, Cáceres, 10003, Spain
-
Hospital Son Espases
Palma de Mallorca, Palma de Mallorca, 07120, Spain
-
Hospital Universitari Quiron Dexeus
Barcelona, Barcelona, 08028, Spain
-
Hospital Universitari Vall d' Hebron
Barcelona, Barcelona, 08035, Spain
-
Hospital Universitario Cruces
Barakaldo, Vizcaya, 48903, Spain
-
Hospital Universitario Fundación Jiménez Díaz
Madrid, Madrid, 28040, Spain
-
Hospital Universitario Insular de Gran canaria
Las Palmas de Gran Canaria, Gran Canaria, 35016, Spain
-
Hospital Universitario La Fe
Valencia, Valencia, 46026, Spain
-
Hospital Universitario Lucus Augusti
Lugo, Lugo, 27003, Spain
-
Hospital Universitario Nuestra Señora La Candelaria
Santa Cruz de Tenerife, Santa Cruz de Tenerife, 38009, Spain
-
Hospital Universitario Virgen de la Arrixaca
El Palmar, El Palmar, 30120, Spain
-
Hospital Universitario de Jaén
Jaén, Jaén, 23007, Spain
-
Hospital Universitario la Paz
Madrid, Madrid, 28046, Spain
-
Hospital Virgen del Rocío
Seville, Sevilla, 41013, Spain
-
Hospital de Basurto
Bilbao, Bilbao, 48013, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Barcelona, 08041, Spain
-
Hospitalario Universitario A Coruña
A Coruña, La Coruña, 15006, Spain
-
ICO Badalona, Hospital Germans Trias i Pujol
Badalona, Barcelona, 08916, Spain
-
ICO Girona, Hospital Josep Trueta
Girona, Girona, 17007, Spain
-
ICO Hospitalet
L'Hospitalet de Llobregat, Barcelona, 08908, Spain
-
Instituto Valenciano De Oncología
Valencia, Valencia, 46009, Spain
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.